Loading organizations...
Grains Valley Venture Capital is a venture capital firm dedicated to investing in early-stage companies within frontier technology sectors. Established in 2007, the firm has specifically concentrated its efforts since 2012 on opportunities across information technology, life sciences, clean technology, and artificial intelligence, seeking to identify and support transformative innovations. Based in Beijing, with operations extending to Shenzhen and Shanghai, the firm provides venture capital, investment management, and consulting services.
The firm commenced operations in 2007, and by 2012, recognized the burgeoning potential of advanced technological industries, shifting its core focus to these areas. This strategic pivot allowed Grains Valley Venture Capital to position itself at the forefront of emerging markets. The leadership team comprises seasoned professionals, each bringing over a decade of experience in venture capital and project management to guide investment decisions.
Grains Valley Venture Capital typically invests in companies from the Angel through Series B-1 stages, supporting visionary entrepreneurs. The firm’s mission is to harness transformation and be deeply immersed in its evolution. Its forward-looking vision centers on empowering humanity's exploration of new technological frontiers, driving progress and innovation for its portfolio companies and the broader ecosystem.
Grains Valley Venture Capital has 2 tracked investments across 2 companies. The latest tracked deal is $28.0M Series B in BridGene Biosciences in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 16, 2025 | BridGene Biosciences | $28.0M Series B | Yuexing SU | Gtja Investment Group, Lapam Capital, Proxima Ventures |
| Aug 15, 2015 | Ascentage Pharma | $15.5M Series A | Oriza Ventures, YuanMing Capital | BioVentures Investors, Efung Capital |